A multicenter, randomized, double-blind, crossover study of patient preference for tadalafil 20 mg or sildenafil citrate 50 mg during initiation of treatment for erectile dysfunction.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples